Investigating how SETD2 affects brain function and its link to Fragile X Syndrome
Mechanisms of Setd2 in cortical circuit function: Convergence with Fragile X Syndrome
This study is looking at how a gene called SETD2 affects brain function and behavior in conditions like autism and Fragile X Syndrome, using mice to learn more about how changes in this gene might help us understand these disorders better and improve care for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11025896 on NIH RePORTER |
What this research studies
This research explores the role of the SETD2 gene in regulating brain function, particularly in relation to autism spectrum disorders (ASD) and Fragile X Syndrome. By studying mice with a specific deletion of the Setd2 gene in their forebrain neurons, researchers aim to understand how changes in histone methylation affect neuronal circuits and behavior. The approach involves examining brain tissue to measure circuit excitability and gene expression, which could reveal important insights into neurodevelopmental disorders. Patients may benefit from a better understanding of the genetic factors contributing to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autism spectrum disorders or those with a family history of Fragile X Syndrome.
Not a fit: Patients without autism spectrum disorders or related neurodevelopmental conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the genetic mechanisms underlying autism and potentially inform future treatments.
How similar studies have performed: Previous research has shown promising results in understanding the role of histone modifications in neurodevelopmental disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Pope, Alexander — Ut Southwestern Medical Center
- Study coordinator: Pope, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.